Innovation’s Medical Research Council

LifeArc, formerly known as Medical Research Council Technology (MRCT) and Medical Research Council Innovations, is a leading UK-based medical research charity that bridges the gap between early-stage scientific discovery and patient treatment. The organization specializes in drug discovery, diagnostics development, and technology transfer, notably through its world-renowned antibody humanization platform which contributed to the development of blockbuster drugs like Keytruda and Actemra. LifeArc operates as a self-funded entity, reinvesting its revenues from royalties and licensing into new research programs focused on rare diseases, global health, and translational science. They provide laboratory facilities, expertise in medicinal chemistry, and funding to accelerate the transition of academic research into clinical applications.